Nula Therapeutics
St. Petersburg, US · Founded 2021 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
CS
Christopher ShepardExecutive
JR
Jarod RutledgeNamed on SEC filing
Board
NR
Nils ReggeBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.4M disclosed across 1 round · 2026
▶$7.4MraisedMar 2026 · 7 investors · BiotechnologyRule 506(b)
▶$7.4MraisedMar 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jarod RutledgeDirector
- Christopher ShepardExecutive Officer, Director
- Nils ReggeDirector
- Offering amount
- $7.4M
- Amount sold
- $7.4M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nula Therapeutics's investors?
- Nula Therapeutics's investors include Korify Capital.
- How much funding has Nula Therapeutics raised?
- Nula Therapeutics has disclosed $7.4M raised across 1 round.
- Where is Nula Therapeutics headquartered?
- Nula Therapeutics is headquartered in St. Petersburg, US.